chevron_leftBack
As of 20 June 2026, U-Neuron Biomedical Inc. has a market cap of $33.78M USD, ranking #33411 globally and #2050 in Taiwan.
It ranks #7627 in the Industrials sector, and #926 in the Specialty Business Services industry.
Key Stats
Market Cap
$33.78MUSD
1.07B TWD
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
Founded
2015
Website
u-neuron.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.1% | -5.2% | -4.9% | -0.7% | -13% | -7.7% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6973
永立榮生醫股份有限公司
ISIN: TW0006973001
Shares Out.:
Shares Outstanding:
39.803M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
36.20 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About U-Neuron Biomedical Inc.
U-Neuron Biomedical Inc engages in the research and development of cell therapy technology and products in Taiwan. It develops stem cells for the treatment of stroke with autologous stem cell transplantation. The company was founded in 2015 and is based in New Taipei City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 2449
|
$10.96B
32K%
346.65B TWD
|
43.7
|
|
TPEX: 3264
|
$2.99B
9K%
94.55B TWD
|
33.6
|
|
TWSE: 6257
|
$2.69B
8K%
84.98B TWD
|
31.1
|
|
TWSE: 7799
|
$1.9B
6K%
60.17B TWD
|
-
|
|
TWSE: 9917
|
$1.61B
5K%
50.84B TWD
|
16.9
|
|
TWSE: 2258
|
$1.57B
5K%
49.77B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: SHOP
|
$158.14B
468K%
|
129.8
|
|
STO: VSURE
|
$131.55B
389K%
114.8B EUR
|
-
|
|
NASDAQ: CTAS
|
$69.6B
206K%
|
36.8
|
|
LSE: REL
|
$62.85B
186K%
47.6B GBP
|
23.9
|
|
NASDAQ: PYPL
|
$45.83B
136K%
|
9.4
|
|
|
T
NEO: TRI
|
$41.8B
124K%
56.91B CAD
|
-
|
chevron_leftBack